GlassScriptPhysician profile
Theodore Flint Gray
NPI 1730199480
$21,218.60
in general payments reported to CMS, 2019-2025
99 companies · $4,301 in 2025
The $4,301 reported for 2025 was more than what 80% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,488 · 2020: $2,791 · 2021: $2,942 · 2022: $2,874 · 2023: $2,821 · 2024: $3,002 · 2025: $4,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,015.49 |
| Education | $108.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,443.89 | 2019-2025 | Enhertu, Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $1,425.21 | 2019-2025 | Piqray, Kisqali |
| Pfizer INC. | $1,164.38 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,125.68 | 2019-2025 | Opdivo, Camzyos, Eliquis |
| Genentech USA, INC. | $1,027.45 | 2019-2025 | Venclexta, Rozlytrek, Alecensa |
| Janssen Biotech, INC. | $955.77 | 2019-2025 | Darzalex, Erleada, Tecvayli |
| Merck Sharp & Dohme LLC | $946.66 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Eisai INC. | $803.98 | 2019-2025 | |
| Genzyme Corporation | $785.07 | 2019-2025 | |
| Daiichi Sankyo INC. | $737.24 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $733.58 | 2019-2025 | Jakafi, Niktimvo, Monjuvi |
| Exelixis INC. | $566.54 | 2019-2025 | Cabometyx |
| Amgen INC. | $541.75 | 2019-2023 | Blincyto, Kyprolis, Vectibix |
| Seagen INC. | $498.23 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Celgene Corporation | $399.92 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $397.37 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $359.27 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Glaxosmithkline, LLC. | $351.79 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Array Biopharma INC | $284.81 | 2020-2025 | Braftovi, Lorbrena, Mektovi |
| Aveo Pharmaceuticals, INC. | $282.52 | 2022-2025 | Fotivda |
| Pharmacyclics LLC, An Abbvie Company | $252.91 | 2019-2023 | Imbruvica, Epkinly |
| Sobi, INC | $251.26 | 2021-2025 | |
| Lilly USA, LLC | $238.68 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Gilead Sciences, INC. | $219.71 | 2019-2025 | Trodelvy |
| Servier Pharmaceuticals LLC | $219.27 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $214.20 | 2019-2025 | Ultomiris |
| Puma Biotechnology, INC. | $206.55 | 2020-2024 | |
| Jazz Pharmaceuticals INC. | $198.90 | 2019-2025 | Zepzelca |
| Abbvie INC. | $166.62 | 2019-2025 | |
| Astellas Pharma US INC | $162.87 | 2020-2025 | Xtandi, Padcev |
| Beone Medicines USA, INC. | $160.81 | 2025 | Brukinsa, Tevimbra |
| Taiho Oncology, INC. | $155.33 | 2020-2025 | |
| Genmab U.S., INC. | $155.26 | 2022-2025 | Epkinly, Tivdak |
| Deciphera Pharmaceuticals INC. | $144.59 | 2020-2025 | Qinlock, Romvimza |
| Karyopharm Therapeutics INC. | $139.14 | 2020-2025 | Xpovio |
| Emd Serono, INC. | $126.92 | 2020-2023 | Bavencio |
| Adc Therapeutics America, INC. | $126.38 | 2022-2025 | |
| Coherus Oncology, INC. | $124.43 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $122.50 | 2019-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $119.78 | 2019-2025 | Onivyde, Somatuline Depot |
| Kite Pharma, INC. | $116.51 | 2020-2025 | Yescarta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.27 | 2021-2023 | Gilotrif |
| Beigene USA, INC. | $104.28 | 2020-2025 | Brukinsa, Tevimbra |
| Sun Pharmaceutical Industries INC. | $94.89 | 2019-2024 | Odomzo, Yonsa |
| Novocure INC. | $90.91 | 2019-2023 | Optune |
| Myriad Genetic Laboratories, INC. | $89.78 | 2023-2024 | Precisetumor, Myrisk |
| Adaptive Biotechnologies Corporation | $88.38 | 2023-2025 | Clonoseq |
| Secura Bio, INC. | $86.46 | 2019-2020 | |
| Organon LLC | $84.13 | 2021-2024 | |
| Acrotech Biopharma INC. | $81.56 | 2022-2025 | Beleodaq |
| Mylan Institutional INC. | $81.42 | 2019-2021 | |
| Springworks Therapeutics, INC. | $79.35 | 2024-2025 | Ogsiveo |
| Stemline Therapeutics INC. | $78.87 | 2023-2024 | Orserdu |
| Octapharma USA, INC. | $76.77 | 2020 | |
| Geron Corporation | $74.01 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $70.33 | 2019-2025 | Pyrukynd |
| Tersera Therapeutics LLC | $67.25 | 2020-2025 | Xermelo |
| Clovis Oncology, INC. | $62.22 | 2019-2020 | |
| Pharmaessentia USA Corporation | $61.68 | 2023-2025 | Besremi |
| Global Blood Therapeutics, INC. | $57.18 | 2020 | |
| Pharmacosmos Therapeutics INC. | $56.88 | 2024-2025 | Cosela, Monoferric |
| Epizyme, INC. | $56.27 | 2020-2022 | |
| Caris Mpi, INC. | $54.43 | 2025 | Mi Cancer Seek |
| Dova Pharmaceuticals | $52.49 | 2019-2021 | |
| Iovance Biotherapeutics, INC. | $51.85 | 2025 | Amtagvi |
| Tempus Ai, INC | $49.90 | 2025 | Xt Cdx |
| Kyowa Kirin, INC. | $48.08 | 2019-2025 | Poteligeo |
| Foundation Medicine, INC. | $47.58 | 2020-2022 | |
| Inari Medical, INC. | $44.60 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Accord Healthcare, INC. | $44.38 | 2024-2025 | |
| Tg Therapeutics, INC. | $44.26 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $39.61 | 2020-2021 | |
| Morphosys, US INC. | $39.50 | 2021 | |
| Spectrum Pharmaceuticals INC. | $38.35 | 2024-2025 | Rolvedon |
| Recordati_rare_diseases_inc. | $38.00 | 2025 | Enjaymo |
| Myovant Sciences INC. | $36.40 | 2021 | |
| Cycle Pharmaceuticals INC | $35.92 | 2025 | Phyrago |
| Mirati Therapeutics, INC. | $34.69 | 2023 | Krazati |
| Celltrion USA INC. | $32.77 | 2025 | Vegzelma |
| Biocon Biologics INC | $31.08 | 2025 | Ogivri |
| Tesaro, INC. | $30.81 | 2019 | |
| Eusa Pharma (US) LLC | $30.81 | 2020-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $29.93 | 2019 | |
| Menarini Silicon Biosystems, INC. | $21.92 | 2025 | |
| Legend Biotech USA INC. | $21.15 | 2025 | Carvykti |
| Sirtex Medical INC | $20.92 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $20.01 | 2025 | Sancuso |
| Immunocore Limited | $18.39 | 2025 | Kimmtrak |
| Amneal Pharmaceuticals LLC | $17.67 | 2023 | Avastin |
| Alnylam Pharmaceuticals INC. | $17.55 | 2025 | Givlaari |
| Medtronic, INC. | $16.62 | 2023 | Osteocool Rf Ablation System |
| Advanced Accelerator Applications | $15.02 | 2019 | |
| Aurobindo Pharma USA, INC. | $13.62 | 2020 | |
| Azurity Pharmaceuticals, INC. | $13.44 | 2024 | Vivimusta |
| Amag Pharmaceuticals, INC. | $12.89 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.48 | 2022 | |
| Verastem, INC. | $11.85 | 2019 | |
| Rigel Pharmaceuticals, INC. | $11.61 | 2020 | |
| Acceleron Pharma, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
Lenvima $500Enhertu $485Kisqali $400Keytruda $356Opdivo $322Nubeqa $245Fotivda $232Lynparza $229Xtandi $215Jakafi $214Cabometyx $203Pluvicto $202Braftovi $186Padcev $176Ultomiris $173Xofigo $171Adcetris $166Elrexfio $161Brukinsa $158Tukysa $148Sarclisa $137Talzenna $136Ibrance $133Lorbrena $131Mektovi $130Trodelvy $128Venclexta $126Darzalex $124Vonjo $120Imfinzi $115Injectafer $112Rozlytrek $111Ojjaara $110Epkinly $109Bosulif $106Orgovyx $102Tagrisso $100Erleada $97.18Alecensa $93.70Xpovio $92.64Imbruvica $92.17Tecvayli $92.13Tecentriq $90.39Clonoseq $88.38Jevtana $88.25Tibsovo $86.68Gavreto $85.69Lutathera $85.10Jemperli $81.18Zejula $81.18Inlyta $80.95Lonsurf $80.48Inqovi $80.48Ogsiveo $79.35Orserdu $78.87Welireg $77.50Reblozyl $76.40Fruzaqla $75.77Rytelo $74.01Precisetumor $73.27Niktimvo $72.42Verzenio $72.32Jaypirca $72.32Vitrakvi $71.07Stivarga $71.07Paxlovid $71.01Talvey $69.72Carvykti $69.59Datroway $68.37Libtayo $67.62Polivy $66.76Avastin $65.39Besremi $61.68Beleodaq $60.66Ninlaro $59.66Qinlock $58.13Calquence $57.73Comirnaty $55.59Pomalyst $55.51Tivdak $55.19Mi Cancer Seek $54.43Retevmo $53.62Piqray $53.29Enjaymo $52.78Eliquis $52.24Amtagvi $51.85Tevimbra $51.84Zepzelca $51.79Xt Cdx $49.90Idhifa $49.68Monjuvi $47.80Blenrep $47.21Elahere $45.60Camcevi $44.38Yonsa $43.59Perjeta $43.54Phesgo $43.54Lunsumio $42.11Yescarta $41.77Akeega $39.80
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.